In the study by Bonazzi et al., whole exome sequencing was performed on endometrial cancers with four common molecular subtypes, including POLE mutations, mismatch repair deficiency (MMRd), p53 mutations, and no specific molecular profile. This evidence concerns the gene TP53 and endometrial cancer.